4.6 Review

The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review

Journal

JOURNAL OF NUTRITION
Volume 151, Issue 7, Pages 1854-1878

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1093/jn/nxab059

Keywords

SARS-CoV-2; COVID-19; nutrition; disease risk; disease progression; micronutrients; systematic review

Funding

  1. Wellcome Trust Our Planet Our Health Programme (FACE-Africa) [216021/Z/19/Z]
  2. Wellcome Clinical PhD Fellowship [203905]
  3. Wellcome Trust [220225/Z/20/Z, 216451/Z/19/Z]
  4. UK Medical Research Council (MRC Human Immunology Unit) [MC_UU_12010/10]
  5. Medical Research Council (UK) [MR/P012019/1]
  6. UK Medical Research Council
  7. Department for International Development (DFID) under the MRC/DFID Concordat agreement (MRC Program) [MC-A760-5QX00]
  8. National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre [IS-BRC-1215-20014]
  9. NIHR
  10. Wellcome Trust [216451/Z/19/Z, 220225/Z/20/Z, 216021/Z/19/Z] Funding Source: Wellcome Trust
  11. MRC [MR/P012019/1, MC_UU_12010/10] Funding Source: UKRI

Ask authors/readers for more resources

Malnutrition may impact susceptibility to and progression of COVID-19, with limited evidence on the effectiveness of high-dose micronutrient supplements in preventing severe disease or expediting recovery. Prevention of obesity and type 2 diabetes shows strong evidence in reducing the risk of serious COVID-19 outcomes.
Background: Many nutrients have powerful immunomodulatory actions with the potential to alter susceptibility to coronavirus disease 2019 (COVID-19) infection, progression to symptoms, likelihood of severe disease, and survival. Objective: The aim was to review the latest evidence on how malnutrition across all its forms funder- and overnutrition and micronutrient status) may influence both susceptibility to, and progression of, COVID-19. Methods: We synthesized information on 13 nutrition-related components and their potential interactions with COVID-19: overweight, obesity, and diabetes; protein-energy malnutrition; anemia; vitamins A, C, D, and E; PUFAs; iron; selenium; zinc; antioxidants; and nutritional support. For each section we provide: 1) a landscape review of pertinent material; 2) a systematic search of the literature in PubMed and EMBASE databases, including a wide range of preprint servers; and 3) a screen of 6 clinical trial registries. All original research was considered, without restriction to study design, and included if it covered: 1) severe acute respiratory syndrome coronavirus (CoV) 2 (SARS-CoV-2), Middle East respiratory syndrome CoV (MFRS-CoV), or SARS-CoV viruses and 2) disease susceptibility or 3) disease progression, and 4) the nutritional component of interest. Searches took place between 16 May and 11 August 2020. Results: Across the 13 searches, 2732 articles from PubMed and EMBASE, 4164 articles from the preprint servers, and 433 trials were returned. In the final narrative synthesis, we include 22 published articles, 38 preprint articles, and 79 trials. Conclusions: Currently there is limited evidence that high-dose supplements of micronutrients will either prevent severe disease or speed up recovery. However, results of clinical trials are eagerly awaited. Given the known impacts of all forms of malnutrition on the immune system, public health strategies to reduce micronutrient deficiencies and undernutrition remain of critical importance. Furthermore, there is strong evidence that prevention of obesity and type 2 diabetes will reduce the risk of serious COVID-19 outcomes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available